Impact of nirsevimab immunization on pediatric RSV-related h

Respiratory syncytial virus (RSV) is one of the main reasons leading to hospitalization among young children worldwide and each year, an estimated 101,000 children below the age of 5 years die due to RSV infections.

Related Keywords

Luxembourg , , European Union , European Centre For Disease Prevention , Disease Prevention , European Economic Area , Respiratory , Respiratory Syncytial Virus , Virus , Ntibody , Children , Laboratory , Monoclonal Antibody , Prophylaxis , Research ,